Clinical Trial Update: Cervicogenic Headache Dose-Response [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial investigating dose-response for cervicogenic headache conducted by the University of Western States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervicogenic Headache

Snippet

Sponsor: University of Western States | Conditions: Cervicogenic Headache | Phase 1, Phase 2 | Status: COMPLETED